Pain Research Unit, Department of Anesthesia and Pain Management, Toronto General Hospital, 200 Elizabeth Street, Eaton North 3 EB 317, Toronto, ON, M5G 2C4, Canada,
Drugs. 2015 Mar;75(4):339-51. doi: 10.1007/s40265-015-0365-2.
Chronic post-surgical pain (CPSP) is a serious complication of major surgery that can impair a patient's quality of life. The development of CPSP is a complex process which involves biologic, psychosocial, and environmental mechanisms that have yet to be fully understood. Currently perioperative pharmacologic interventions aim to suppress and prevent sensitization with the aim of reducing pain and analgesic requirement in acute as well as long-term pain . Despite the detrimental effects of CPSP on patients, the body of literature focused on treatment strategies to reduce CPSP remains limited and continues to be understudied. This article reviews the main pharmacologic candidates for the treatment of CPSP, discusses the future of preventive analgesia, and considers novel strategies to help treat acute post-operative pain and lessen the risk that it becomes chronic. In addition, this article highlights important areas of focus for clinical practice including: multimodal management of CPSP patients, psychological modifiers of the pain experience, and the development of a Transitional Pain Service specifically designed to manage patients at high risk of developing chronic post-surgical pain.
慢性术后疼痛(CPSP)是一种严重的大手术并发症,会损害患者的生活质量。CPSP 的发展是一个复杂的过程,涉及生物学、心理社会和环境机制,但尚未完全了解。目前,围手术期药物干预旨在抑制和预防敏化,以减少急性和长期疼痛中的疼痛和镇痛需求。尽管 CPSP 对患者有不利影响,但针对减少 CPSP 的治疗策略的文献仍然有限,并且仍在进行研究。本文综述了治疗 CPSP 的主要药物候选物,讨论了预防性镇痛的未来,并考虑了治疗急性术后疼痛和降低其发展为慢性疼痛风险的新策略。此外,本文还强调了临床实践的一些重点关注领域,包括:CPSP 患者的多模式管理、疼痛体验的心理调节剂,以及专门设计用于管理有发生慢性术后疼痛高风险患者的过渡性疼痛服务的发展。